---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-031772"
form_type: "8-K"
ticker: "DSGN"
cik: "0001807120"
company_name: "Design Therapeutics, Inc."
filed_at: "2026-01-30T23:59:59+00:00"
generated_at: "2026-05-16T06:01:58.305785+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Design Therapeutics board member Deepa Prasad resigns effective Feb 1, 2026

## Summary
- Deepa Prasad resigned from Design Therapeutics Board of Directors effective February 1, 2026.
- Resignation due to conflict-avoidance policies associated with her new role at a major bank.
- No replacement or other board changes announced; remaining directors continue in office.

## SEC filing metadata
- accession: 0001193125-26-031772
- form_type: 8-K
- ticker: DSGN
- cik: 0001807120
- company_name: Design Therapeutics, Inc.
- filed_at: 2026-01-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1807120/000119312526031772/0001193125-26-031772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1807120/000119312526031772/d14213d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-031772
- JSON: https://secwatch.observer/filing/0001193125-26-031772.json
- Plain text: https://secwatch.observer/filing/0001193125-26-031772.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.